Patents Assigned to TRINUTRA LTD.
  • Compositions comprising thymoquinone and omega-3 fatty acids
    Patent number: 11426365
    Abstract: The present invention provides a composition comprising a synergistic combination of thymoquinone and one or more omega-3 fatty acids, wherein the molar ratio between said thymoquinone and said one or more omega-3 fatty acids is at least 1:7. The present invention also provides a method of using said composition to treat or prevent inflammatory conditions.
    Type: Grant
    Filed: July 15, 2018
    Date of Patent: August 30, 2022
    Assignee: Trinutra Ltd.
    Inventors: Yoram Sela, Mor Zeilkha, Itschak Lamensdorf
  • Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine
    Patent number: 11266701
    Abstract: The present invention provides a therapeutic composition comprising a synergistic combination of caffeine, Ginkgo biloba, and ?-phenylethylamine (PEA) or its salt. The invention is also directed to oral dosage forms containing said composition, and to a method of treatment of a psychological, psychiatric, behavioral and/or neurodevelopmental disorder comprising the administration of said compositions and dosage forms to a patient in need thereof.
    Type: Grant
    Filed: November 13, 2018
    Date of Patent: March 8, 2022
    Assignee: TRINUTRA LTD.
    Inventors: Itschak Lamensdorf, Yoram Sela, Mor Zeilkha
  • Compositions comprising melatonin
    Patent number: 10675269
    Abstract: The present invention provides a composition comprising a synergistic combination of melatonin, valerenic acid and carnosic acid. The composition may be used in the treatment and prevention of several different disorders including inflammatory conditions, sleep disorders and anxiety. The invention also relates to several dosage forms which are suitable for the delivery of the claimed composition to subjects in need of treatment therewith.
    Type: Grant
    Filed: January 17, 2017
    Date of Patent: June 9, 2020
    Assignee: TRINUTRA LTD.
    Inventors: Yoram Sela, Mor Zeilkha, Itschak Lamensdorf
  • COMPOSITIONS COMPRISING MELATONIN
    Publication number: 20190029999
    Abstract: The present invention provides a composition comprising a synergistic combination of melatonin, valerenic acid and carnosic acid. The composition may be used in the treatment and prevention of several different disorders including inflammatory conditions, sleep disorders and anxiety. The invention also relates to several dosage forms which are suitable for the delivery of the claimed composition to subjects in need of treatment therewith.
    Type: Application
    Filed: January 17, 2017
    Publication date: January 31, 2019
    Applicant: TRINUTRA LTD.
    Inventors: Yoram SELA, Mor ZEILKHA, Itschak LAMENSDORF
  • Synergistic combinations of caffeine, ginkgo biloba and beta-phenylethylamine
    Patent number: 10159702
    Abstract: The present invention provides a therapeutic composition comprising a synergistic combination of caffeine, ginkgo biloba, and ?-phenylethylamine (PEA) or its salt. The invention is also directed to oral dosage forms containing said composition, and to a method of treatment of a psychological, psychiatric, behavioral and/or neurodevelopmental disorder comprising the administration of said compositions and dosage forms to a patient in need thereof.
    Type: Grant
    Filed: December 14, 2017
    Date of Patent: December 25, 2018
    Assignee: TRINUTRA LTD.
    Inventors: Itschak Lamensdorf, Yoram Sela, Mor Zeilkha